<DOC>
	<DOCNO>NCT00063583</DOCNO>
	<brief_summary>The purpose study determine whether new investigational drug , pirfenidone , effective therapy diabetic patient kidney dysfunction . Our hypothesis administration pirfenidone type 1 type 2 diabetic patient advance kidney disease lead preservation kidney function .</brief_summary>
	<brief_title>Pirfenidone : A New Drug Treat Kidney Disease Patients With Diabetes</brief_title>
	<detailed_description>Diabetic kidney disease lead cause new case kidney failure United States . In kidney diabetic patient , accumulation protein lead formation scar tissue poor kidney function . Because many patient eventually require dialysis kidney transplantation . A new investigational drug , pirfenidone , show beneficial number disease scar formation lead disease progression . It goal examine whether pirfenidone effective stabilize reduce progressive diabetic kidney dysfunction .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Pirfenidone</mesh_term>
	<criteria>Inclusion Type 1 type 2 diabetes Males female great equal 18 year . Abnormal kidney function determine glomerular filtration rate History proteinuria Blood pressure control &lt; 140/90 antihypertensive medication Exclusion Cancer , liver disease , hepatitis , HIV+ History heart attack , unstable angina , stroke peptic ulcer past 6 month Pregnant plan become pregnant study period Other know kidney disease besides diabetic nephropathy Expect begin dialysis receive kidney transplant within 1 year study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Kidney disease</keyword>
</DOC>